Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1996Epilepsia

Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy

View Full Paper
Ask AI
Bookmark
Share

Authors

CTC. A. TassinariUniversity of VeronaRMRoberto MichelucciIstituto delle Scienze Neurologiche di BolognaPCPatrick ChauvelCleveland Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tassinari et al. (1996) studied this question.

synapsesocial.com/papers/6a71ca93fe4101aa97e0ad37https://doi.org/10.1111/j.1528-1157.1996.tb00649.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Felbamate in the Treatment of Lennox‐Gastaut Syndrome1994 · 66 citations
  2. 2New and investigational antiepilepsy drugs1994 · 8 citations
  3. 3Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures1996 · 244 citations
  4. 4Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages1996 · 339 citations